CD5 and diffuse large B-cell lymphoma: To compare the clinicopathologic findings between the CD5+ and CD5- groups, a total of 166 CD5-DLBCL, which had no evidence of transformation from low grade lymphoma, were selected, of which detailed clinical data and sufficient tissue for further pathologic studies were available.